Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
149
datasets available to search
ShareScore release 0.9.0
Dataset results
149 results for “vedolizumab”
Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab
ClinicalTrials.gov study NCT03798691. IPD Sharing: NO. Countries: 1. Publications: 1.
Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT
ClinicalTrials.gov study NCT02728895. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
ClinicalTrials.gov study NCT03558152. IPD Sharing: YES. Countries: 16. Publications: 1.
Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease
ClinicalTrials.gov study NCT02630966. IPD Sharing: YES. Countries: 7. Publications: 1.
Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab
ClinicalTrials.gov study NCT01981616. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
ClinicalTrials.gov study NCT06227910. IPD Sharing: YES. Countries: 26. Publications: 1.
Defining Predictors of RT Response to Vedolizumab in IBD
ClinicalTrials.gov study NCT03142321. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitis
ClinicalTrials.gov study NCT04006080. IPD Sharing: NO. Countries: 1. Publications: 8.
Using Vedolizumab-800CW to Gain Insight Into Local Drug Distribution and Mucosal Target Cells in IBD Patients
ClinicalTrials.gov study NCT04112212. IPD Sharing: NO. Countries: 1. Publications: 3.
The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis
ClinicalTrials.gov study NCT02721719. IPD Sharing: NO. Countries: 1. Publications: 31.
Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
ClinicalTrials.gov study NCT03196427. IPD Sharing: YES. Countries: 7. Publications: 0.
A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study
ClinicalTrials.gov study NCT02646683. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection
ClinicalTrials.gov study NCT03147859. IPD Sharing: YES. Countries: 1. Publications: 2.
The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness
ClinicalTrials.gov study NCT02423512. IPD Sharing: Not stated. Countries: 1. Publications: 4.
CurQD as Add-On Therapy in Vedolizumab-Treated Ulcerative Colitis Patients: Retrospective Cohort Study
ClinicalTrials.gov study NCT07240168. IPD Sharing: NO. Countries: 1. Publications: 10.
Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases
ClinicalTrials.gov study NCT02862132. IPD Sharing: UNDECIDED. Countries: 6. Publications: 3.
VedAryo® (Vedolizumab) Effectiveness and Safety Evaluation
ClinicalTrials.gov study NCT07273760. IPD Sharing: NO. Countries: 1. Publications: 2.
Vedolizumab Induction May Prevent Celiac Enteritis
ClinicalTrials.gov study NCT02929316. IPD Sharing: NO. Countries: 1. Publications: 9.
A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease
ClinicalTrials.gov study NCT04804540. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
ClinicalTrials.gov study NCT04738942. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.